These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 23589213)
1. A role for adjuvant RFA in managing hepatic metastases from gastrointestinal stromal tumors (GIST) after treatment with targeted systemic therapy using kinase inhibitors. Hakimé A; Le Cesne A; Deschamps F; Farouil G; Boudabous S; Aupérin A; Domont J; Debaere T Cardiovasc Intervent Radiol; 2014 Feb; 37(1):132-9. PubMed ID: 23589213 [TBL] [Abstract][Full Text] [Related]
2. Reply to Letter: A Role for Adjuvant RFA in Managing Hepatic Metastases From Gastrointestinal Stromal Tumors (GIST) After Treatment With Targeted Systemic Therapy Using Kinase Inhibitors. Hakimé A; Le Cesne A; Deschamps F; Farouil G; Domont J; De Baere T Cardiovasc Intervent Radiol; 2015 Jun; 38(3):776-7. PubMed ID: 23912492 [No Abstract] [Full Text] [Related]
3. Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China. Chen Q; Li C; Yang H; Zhao H; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):317-323. PubMed ID: 30447909 [TBL] [Abstract][Full Text] [Related]
4. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression. Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of tyrosine kinase inhibitor therapy combined with surgical resection in patients with metastatic gastrointestinal stromal tumor]. Zhang XH; He YL; Chen CQ; Zhan WH; Ma JP; Cai SR; Wu KM; Chen JH Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Jul; 13(7):502-5. PubMed ID: 20658363 [TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation is a valuable therapeutic option in the treatment of liver metastases from gastrointestinal stromal tumors. Sun QK; Wang W; Jia WD Cardiovasc Intervent Radiol; 2014 Apr; 37(2):552-3. PubMed ID: 23917966 [No Abstract] [Full Text] [Related]
7. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour. Cananzi FC; Belgaumkar AP; Lorenzi B; Mudan S ANZ J Surg; 2014 Dec; 84(12):E1-8. PubMed ID: 23647808 [TBL] [Abstract][Full Text] [Related]
8. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour. Cananzi FC; Belgaumkar A; Lorenzi B; Mudan S ANZ J Surg; 2014 Dec; 84(12):937-42. PubMed ID: 25444423 [TBL] [Abstract][Full Text] [Related]
9. Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST). Hohenberger P; Eisenberg B Ann Surg Oncol; 2010 Oct; 17(10):2585-600. PubMed ID: 20407930 [TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease. Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors. Liu L; Wang B; Zhang ZY; Wang S; Wu H; Wang H; Wu W; Yan K; Yang W Int J Hyperthermia; 2024; 41(1):2292950. PubMed ID: 38159558 [TBL] [Abstract][Full Text] [Related]
12. [A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib]. Sakakura C; Miyagawa K; Fukuda K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Yamaoka N; Sagara Y; Hagiwara A; Yamagishi H Gan To Kagaku Ryoho; 2005 Oct; 32(11):1739-41. PubMed ID: 16315926 [TBL] [Abstract][Full Text] [Related]
13. Management of liver metastases of gastrointestinal stromal tumors (GIST). Vassos N; Agaimy A; Hohenberger W; Croner RS Ann Hepatol; 2015; 14(4):531-9. PubMed ID: 26019040 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587 [TBL] [Abstract][Full Text] [Related]
15. The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST. An HJ; Ryu MH; Ryoo BY; Sohn BS; Kim KH; Oh ST; Yu CS; Yook JH; Kim BS; Kang YK Ann Surg Oncol; 2013 Dec; 20(13):4212-8. PubMed ID: 24052319 [TBL] [Abstract][Full Text] [Related]
16. Understanding rechallenge and resistance in the tyrosine kinase inhibitor era: imatinib in gastrointestinal stromal tumor. Agulnik M; Giel JL Am J Clin Oncol; 2014 Aug; 37(4):417-22. PubMed ID: 22772433 [TBL] [Abstract][Full Text] [Related]